An Investigation of the Correlation Between Il-8, Il-10 and Nutritional Proteins in Patients with Sleep Disorders in Chronic Obstructive Pulmonary Disease
Abstract
Introduction: Chronic obstructive pulmonary disease (COPD) is one of the most common respiratory diseases worldwide, with an increasing incidence in recent years. In this study, we analyzed the relationship between Interleukin-8 (IL-8), Interleukin-10 and COPD to provide reference for clinical diagnosis and treatment in the future.
Material and methods: A randomized controlled trial was conducted on 56 COPD patients and 56 concurrent healthy volunteers who visited our hospital from March 2022 to December 2022. Among them, COPD patients served as the research group and healthy volunteers served as the control group. To compare the IL-8 and IL-10 of the two groups and to analyze the relationship between IL-8, IL-10 and lung function, nutrient proteins, clinical efficacy and prognosis of the research group.
Results: IL-8 was higher in the study group than in the control group, and was negatively correlated with lung function indices and nutrient proteins (P<0.05). IL-10 in the research group was lower than that in the control group, and there was a positive correlation with lung function indexes and nutritional proteins (P<0.05). After treatment, IL-8 was lower and IL-10 was higher in the research group (P<0.05). In addition, IL-8 and IL-10 in the research group demonstrated excellent assessment of COPD occurrence, sleep disturbance, and prognostic recurrence.
Conclusion: IL-8, IL-10 not only directly participate in the occurrence of COPD by affecting the human immune microcirculation, but also accelerate the progression of COPD by causing malnutrition.
Copyright (c) 2025 Mei Liang, Mei Zhou, Xiaofeng Fu, Qianyun Zhou, Liang Li
This work is licensed under a Creative Commons Attribution 4.0 International License.
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.